NNNN
Anbio Biotechnology
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$3.27
+4.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.79x
- PEG TTM
- 0.45x
- Price / book
- 4.76x
- Price / sales
- 16.60x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $131.6M
- EV / sales
- 15.22x
- EV / EBITDA
- 20.32x
- EV / EBIT
- 22.82x
- Market cap
- $143.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025